Mode
Text Size
Log in / Sign up
N/A N=400 Randomized Prevention

Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients

Colorectal Cancer

Enrolled (actual)
400
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Overall Screening Adherence — 88; 153; 115; 44 Participants — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Decision Support & Navigation (Behavioral); Standard (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
Thomas Jefferson University
Primary completion
Jan 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Screening Adherence
88; 153; 115; 44 <0.001 sig
SECONDARY
Change in Screening Decision Stage
61; 97; 52; 23; 10; 3 <0.001 sig
SECONDARY
Test Specific Screening Adherence
115; 44; 76; 113; 12; 40 <0.001 sig
SECONDARY
Screening Knowledge and Perceptions
3.8; 3.8; 4.8; 4.7; 4.5; 4.5 0.862

Summary

This study is designed to test a standard mailed intervention (SI) versus a novel decision support and navigation intervention (DSNI). Working with patients and stakeholders, this randomized trial will include 400 Hispanic men and women who are 50 to 75 years of age, patients in community based primary care practices, and are eligible for CRC screening. We will consent, survey, and randomize participants either to the SI Group (n=200) or the DSNI Group (n=200). Study specific aims are to: (1) Assess intervention (DSNI versus SI) impact on overall CRC screening adherence; (2)Assess intervention (DNSI versus SI) impact on CRC screening decision stage; (3) Assess intervention (DNSI versus SI) impact on test-specific CRC screening adherence; and (4) Assess intervention (DNSI versus SI) impact on CRC and knowledge and perceptions.

Eligibility Criteria

Inclusion Criteria

  • Male or Female
  • Self-identifies as being Hispanic or Latino
  • 50 to 75 years of age

Exclusion Criteria

  • Previous diagnosis of CRC
  • Up to date with CRC screening guidelines.
  • Personal history of inflammatory bowel disease
  • Personal history of polyps
  • Family history of CRC diagnosed before the age of 60 years
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02272244). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search